Arina Riabinska

Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL

Alexandra Schrader, Giuliano Crispatzu, Sebastian Oberbeck et al. · Nature Communications · 2018 · 105 citations · Full text

Life Sciences, Genetics, Oncology +17

Therapeutic Targeting of a Robust Non-Oncogene Addiction to <i>PRKDC</i> in <i>ATM</i> -Defective Tumors

Arina Riabinska, Mathias Daheim, Grit S. Herter-Sprie et al. · Science Translational Medicine · 2013 · 101 citations

Life Sciences, Cancer Biology, Oncology +17

Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia

Gero Knittel, Tim Rehkämper, Darya Korovkina et al. · Nature Communications · 2017 · 55 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Posttranscriptional regulation of gene expression—adding another layer of complexity to the DNA damage response

Jorge Bouças, Arina Riabinska, Mladen Jokić et al. · Frontiers in Genetics · 2012 · 39 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle Progression

Jorge Bouças, Christian Fritz, Anna Schmitt et al. · PLoS ONE · 2015 · 38 citations · Full text

Life Sciences, Molecular Biology, Gene Expression +15